Pembrolizumab-induced linear psoriasis

Lung Cancer. 2020 Aug:146:378-379. doi: 10.1016/j.lungcan.2020.06.012. Epub 2020 Jun 17.

Authors

Po-Wei Huang¹, Chia-Yu Chu²

Affiliations

¹ Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-Shan South Road, Taipei, 10002, Taiwan. Electronic address: benny1990615@gmail.com.
² Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-Shan South Road, Taipei, 10002, Taiwan. Electronic address: chiayu@ntu.edu.tw.

PMID: 32586659
DOI: 10.1016/j.lungcan.2020.06.012

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Lung Neoplasms*
Psoriasis* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab